$2,040,000 of CVS HEALTH (AND SUBSIDIARIES) lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to retail pharmacy, drug pricing, and women's health. H.R. 1770, The Equitable Community Access to Pharmacist Services Act S. 2477, The Equitable Community Access to Pharmacist Services Act Issues related to the corporate tax rate. Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to COVID testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. S. 1339 - Pharmacy Benefit Manager Reform Act of 2023 S. 1967 - Patients Before Middlemen Act of 2023 S. 2973 - Modernizing and Ensuring PBM Accountability (MEPA) Act S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R. 2679 - Pharmacy Benefit Manager Accountability Act of 2023 H.R. 3285 - Fairness for Patient Medications Act H.R. 1613 - Drug Price Transparency in Medicaid Act of 2023 H.R. 3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023 H.R. 5378 - Lower Costs, More Transparency Act H.R. 2880 - Protecting Patients Against PBM Abuses Act Issues related to employer, small group and individual insurance markets. S. 1542/H.R. 6283 - Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 10455 - To direct the Secretary of Health and Human Services to establish the Health Sector Cybersecurity Coordination Center, and for other purposes. Issues related to pharmacy benefit managers. H.R. 10545 - the American Relief Act, 2025.Issues related to pharmacy benefit managers. Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues. Issues related to organized retail crime and consumer safety."
You can find more data on corporate lobbying on Quiver Quantitative.
CVS Congressional Stock Trading
Members of Congress have traded $CVS stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CVS stock by members of Congress over the last 6 months:
- REPRESENTATIVE THOMAS R. SUOZZI sold up to $15,000 on 10/24.
- SENATOR TOMMY TUBERVILLE sold up to $15,000 on 08/26.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CVS Hedge Fund Activity
We have seen 574 institutional investors add shares of CVS stock to their portfolio, and 1,245 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 29,811,224 shares (-84.1%) from their portfolio in Q3 2024, for an estimated $1,874,529,765
- CAPITAL WORLD INVESTORS removed 7,803,220 shares (-13.9%) from their portfolio in Q3 2024, for an estimated $490,666,473
- CAPITAL INTERNATIONAL INVESTORS added 4,716,600 shares (+22.7%) to their portfolio in Q3 2024, for an estimated $296,579,808
- MILLENNIUM MANAGEMENT LLC added 4,612,765 shares (+724.2%) to their portfolio in Q3 2024, for an estimated $290,050,663
- BLACKROCK, INC. added 4,398,293 shares (+4.4%) to their portfolio in Q3 2024, for an estimated $276,564,663
- AMUNDI added 3,404,002 shares (+136.7%) to their portfolio in Q3 2024, for an estimated $214,043,645
- TWO SIGMA INVESTMENTS, LP added 3,123,936 shares (+3205.7%) to their portfolio in Q3 2024, for an estimated $196,433,095
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
